Teva Pharmaceutical Industries Ltd. ADR-0.93% $19.32B ...
The aim was to update the 2009 European League against Rheumatism (EULAR) recommendations for the treatment of systemic sclerosis (SSc), with attention to new therapeutic questions. Update of the ...
GlaxoSmithKline PLC creates, discovers, develops, manufactures and markets pharmaceutical products including respiratory and antiviral, vaccines, over-the-counter (OTC) medicines and health-related ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback